Chronic Hepatitis B
📧 Sign up to get email alerts when something new happens for Chronic Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-23Clinical Trial Results: Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection [Phase 2]
Phase 2 study assessing the safety and efficacy of BRII-835 and BRII-179 combo therapy for chronic hepatitis B; results completed and posted…
-
EMA approval · 2026-07-22EMA Authorised: Zeffix (lamivudine) — GlaxoSmithKline Trading Services Limited
Zeffix (lamivudine) has been authorised by EMA for chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Update: Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) [Phase 3]
Phase 3 trial update for Bepirovirsen in nucleos(t)ide analogue–treated chronic hepatitis B patients; study completed.
-
CLINICAL_TRIALS trial_result · 2026-07-08Clinical Trial Update: Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1) [Phase 3]
Phase 3 clinical trial update for Bepirovirsen in nucleos(t)ide analogue–treated participants with chronic hepatitis B has completed.